<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05119478</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0612</org_study_id>
    <nct_id>NCT05119478</nct_id>
  </id_info>
  <brief_title>Evaluation of Sensitization to Peach and/or Cypress in Potato Sensitized Patients in a Large Cohort</brief_title>
  <acronym>CYPPOT</acronym>
  <official_title>Prevalence of Sensitization to Peach and/or Cypress in Potato Sensitized Patients in Occitania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study will be to investigate the prevalence of of sensitization to peach&#xD;
      and/or cypress in potato sensitized patients, based on the collection of medical data from&#xD;
      patient records consulting in the Allergy Unit of the Arnaud de Villeneuve Hospital.&#xD;
&#xD;
      Some Gibberellin-regulated protein (GRP) in fruits and pollens have been identified as&#xD;
      allergen, and peach GRP (peamaclein) has recently emerged as a relevant food allergen in&#xD;
      cypress pollen-hypersensitive patients. Multiple fruit allergies might be related to&#xD;
      cross-reactivity between GRPs. Peamaclein shares 82% identity with snakin-1 from potato.&#xD;
      Thus, because of this hight homology the investigators want to determine the prevalence of&#xD;
      cosensitization between these 3 allergens potato, peach and cypress.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of sensitization to peach and/or cypress in potato-sensitized patients</measure>
    <time_frame>day 1</time_frame>
    <description>Rate of sensitization to peach and/or cypress in potato-sensitized patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of of sensitization to peach and/or cypress in potato-sensitized patients</measure>
    <time_frame>day 1</time_frame>
    <description>Rate of sensitization to peach and/or cypress in potato-sensitized patients (cypress pollen-induced allergic rhinitis or food allergy to peach)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">594</enrollment>
  <condition>Allergic Rhinitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients consulting in the Allergy Unit of the Arnaud de Villeneuve Hospital with positive&#xD;
        skin prick test to potato&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patients evaluated at the Montpellier University Hospital, Allergy Unit&#xD;
&#xD;
          -  children and adult with positive skin prick test to potato from february 2013 to&#xD;
             december 2015&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patients under legal protection&#xD;
&#xD;
          -  Patients under guardianship or under curatorship&#xD;
&#xD;
          -  Patients not capable of understanding French&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davide CAIMMI</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Davide CAIMMI, MD</last_name>
    <phone>467336112</phone>
    <phone_ext>33</phone_ext>
    <email>davide.caimmi@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Evang√©line CLARK, doctor</last_name>
    <phone>467336107</phone>
    <email>e-clark@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide CAIMMI, MD</last_name>
      <phone>467336112</phone>
      <phone_ext>33</phone_ext>
      <email>davide.caimmi@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 27, 2021</study_first_submitted>
  <study_first_submitted_qc>November 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cypress</keyword>
  <keyword>gibberellin-regulated protein</keyword>
  <keyword>peach</keyword>
  <keyword>potato</keyword>
  <keyword>rhinitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

